Risk-adapted therapy using biopsy confirmation of abnormal interim FDG-PET for patients with advanced stage diffuse large B cell lymphoma (DLBCL), and exploratory evaluation of FLT-PET Meeting Abstract


Authors: Moskowitz, C. H.; Schoder, H.; Hamlin, P. A.; Gerecitano, J. F.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Palomba, M.; Portlock, C. S.; Straus, D. J.; Graustein, T. A.; Teruya-Feldstein, J.; Zelenetz, A. D.
Abstract Title: Risk-adapted therapy using biopsy confirmation of abnormal interim FDG-PET for patients with advanced stage diffuse large B cell lymphoma (DLBCL), and exploratory evaluation of FLT-PET
Meeting Title: 11th International Conference on Malignant Lymphoma
Journal Title: Annals of Oncology
Volume: 22
Issue: Suppl. 4
Meeting Dates: 2011 Jun 15-18
Meeting Location: Lugano, Switzerland
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2011-06-01
Start Page: iv158
Language: English
ACCESSION: WOS:000291996300234
PROVIDER: wos
DOI: 10.1093/annonc/mdr217
PUBMED: 21714157
Notes: Meeting Abstract: 220 -- "Source: Wos"
Altmetric Score
MSK Authors
  1. Carol Portlock
    180 Portlock
  2. Craig Moskowitz
    374 Moskowitz
  3. Ariela Noy
    206 Noy
  4. Maria Lia Palomba
    128 Palomba
  5. Julie T Feldstein
    288 Feldstein
  6. Steven M Horwitz
    360 Horwitz
  7. Heiko Schoder
    287 Schoder
  8. Andrew D Zelenetz
    554 Zelenetz
  9. Alison Moskowitz
    147 Moskowitz
  10. Paul Hamlin
    173 Hamlin
  11. Matthew J Matasar
    121 Matasar
  12. David J Straus
    213 Straus
Related MSK Work